Showing 20 of 132 recruiting trials for “frontotemporal-dementia-with-motor-neuron-disease”
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
RecruitingNCT05288842 ↗
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Virtual Peer-to-peer Support Programme for Carers of MND
RecruitingNCT05033951 ↗
Optimizing INITIation of Non-invasive Ventilation in ALS Patients
RecruitingNCT04865172 ↗
ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions
👨⚕️ Richard Levy, MD, PhD, Institut National de la Santé Et de la Recherche Médicale, France📍 1 site📅 Started May 2022View details ↗
RecruitingNCT05354622 ↗
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
👨⚕️ Darius Ebrahimi-Fakhari, MD, PhD, Boston Children's Hospital📍 1 site📅 Started Apr 2022View details ↗
A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS
Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease
Investigation on the Cortical Communication (CortiCom) System
The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias
A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study
A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes
RecruitingNCT05204017 ↗
Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)
Enrolling by InvitationNCT04961450 ↗
Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
RecruitingNCT05137665 ↗
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
Longitudinal Assessment of Autonomic and Sensory Nervous System in ALS
👨⚕️ Maria Nolano, MD, PhD, Istituti Clinici Scientifici Maugeri SpA📍 2 sites📅 Started May 2021View details ↗
RecruitingNCT04885374 ↗
China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
👨⚕️ Albert Ludolph, MD, PhD, Department of Neurology, University of Ulm, Germany📍 56 sites📅 Started Feb 2021View details ↗
RecruitingNCT04394871 ↗
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing
👨⚕️ Christopher Grunseich, M.D., National Institute of Neurological Disorders and Stroke (NINDS)📍 1 site📅 Started Dec 2020View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →